BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 26621445)

  • 1. Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice.
    Han SY; Choi YJ; Kang MK; Park JH; Kang YH
    Am J Chin Med; 2015; 43(8):1605-23. PubMed ID: 26621445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits IgE-mediated basophilic mast cell degranulation and passive cutaneous anaphylaxis in mice.
    Han SY; Bae JY; Park SH; Kim YH; Park JH; Kang YH
    J Nutr; 2013 May; 143(5):632-9. PubMed ID: 23514766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
    Han EH; Park JH; Kim JY; Jeong HG
    Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway.
    Kim YY; Je IG; Kim MJ; Kang BC; Choi YA; Baek MC; Lee B; Choi JK; Park HR; Shin TY; Lee S; Yoon SB; Lee SR; Khang D; Kim SH
    Acta Pharmacol Sin; 2017 Jan; 38(1):90-99. PubMed ID: 27890918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells.
    Shirley D; McHale C; Gomez G
    Biochim Biophys Acta; 2016 Apr; 1860(4):678-85. PubMed ID: 26777630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licarin A is a candidate compound for the treatment of immediate hypersensitivity via inhibition of rat mast cell line RBL-2H3 cells.
    Matsui T; Ito C; Masubuchi S; Itoigawa M
    J Pharm Pharmacol; 2015 Dec; 67(12):1723-32. PubMed ID: 26376734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
    Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
    J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hispidulin Inhibits Mast Cell-Mediated Allergic Inflammation through Down-Regulation of Histamine Release and Inflammatory Cytokines.
    Kim DE; Min KJ; Kim MJ; Kim SH; Kwon TK
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31195760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of the branches of Hovenia dulcis Thunb. and its constituent pinosylvin on the activities of IgE-mediated mast cells and passive cutaneous anaphylaxis in mice.
    Lim SJ; Kim M; Randy A; Nho CW
    Food Funct; 2015 Apr; 6(4):1361-70. PubMed ID: 25804702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extract of
    Lim JY; Lee JH; Lee BR; Kim MA; Lee YM; Kim DK; Choi JK
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
    Péterfy H; Tóth G; Pecht I; Erdei A
    Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic environment augments FcεRI-mediated production of IL-6 and IL-13 in mast cells.
    Kamide Y; Ishizuka T; Tobo M; Tsurumaki H; Aoki H; Mogi C; Nakakura T; Yatomi M; Ono A; Koga Y; Sato K; Hisada T; Dobashi K; Yamada M; Okajima F
    Biochem Biophys Res Commun; 2015 Aug; 464(3):949-55. PubMed ID: 26196745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of Acorus calamus extracts on mast cell-dependent anaphylactic reactions using mast cell and mouse model.
    Kim DY; Lee SH; Kim WJ; Jiang J; Kim MK; Shin YK; Kim DW; Moon WK; Kwon SC; Koppula S; Kang TB; Lee KH
    J Ethnopharmacol; 2012 May; 141(1):526-9. PubMed ID: 22366435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaves and pseudostems extract of Curcuma longa attenuates immunoglobulin E/bovine serum albumin-stimulated bone marrow-derived cultured mast cell activation and passive cutaneous anaphylaxis in BALB/c mice.
    Jayasinghe AMK; Kirindage KGIS; Kim SH; Lee S; Kim KN; Kim EA; Heo SJ; Ahn G
    J Ethnopharmacol; 2024 Mar; 321():117529. PubMed ID: 38042384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization.
    Sancho-Serra Mdel C; Simarro M; Castells M
    Eur J Immunol; 2011 Apr; 41(4):1004-13. PubMed ID: 21360700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo.
    Kim JW; Lee JH; Hwang BY; Mun SH; Ko NY; Kim DK; Kim B; Kim HS; Kim YM; Choi WS
    Biochem Pharmacol; 2009 May; 77(9):1506-12. PubMed ID: 19426688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
    MacNeil AJ; Yang YJ; Lin TJ
    J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: involvement of p38 MAPK.
    Boudreau RT; Hoskin DW; Lin TJ
    J Leukoc Biol; 2004 Nov; 76(5):1075-81. PubMed ID: 15316034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase.
    Ishizuka T; Okajima F; Ishiwara M; Iizuka K; Ichimonji I; Kawata T; Tsukagoshi H; Dobashi K; Nakazawa T; Mori M
    J Immunol; 2001 Aug; 167(4):2298-304. PubMed ID: 11490018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.